Laxxon Medical to Present Innovative Oral GLP-1 Agonist with Multi-Compartment Micro-Tablet Form, Aiming to Enhance Patient Compliance for Special Patient Groups, at the 2024 BIO Europe Convention
NEW YORK, NY / ACCESSWIRE / October 4, 2024 / Laxxon Medical, a US-based pharma-technology company pioneering a new generation of advanced oral drug delivery systems, announced today its participation in the 2024 BIO-Europe Convention from November 4-6, 2024 in Stockholm, Sweden. This year at BIO-Europe, Laxxon Medical is showcasing its LXM.2 asset, a non-invasive, […]